Jerry Di Salvo Selected Research

Adrenergic Agonists (Adrenergic Receptor Agonist)

1/2017	Investigation of piperazine benzamides as human β3 adrenergic receptor agonists for the treatment of overactive bladder.
1/2016	Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.
2/2014	Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerry Di Salvo Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 07/2017 - 06/2006
3	Overactive Urinary Bladder (Overactive Bladder) 01/2017 - 02/2014
2	Insulin Resistance 01/2017 - 08/2014
2	Weight Gain 01/2017 - 01/2017
2	Body Weight (Weight, Body) 01/2017 - 01/2017
1	Hypoglycemia (Reactive Hypoglycemia) 02/2017
1	Hyperglycemia 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 08/2014
1	Atherosclerosis 08/2014
1	Hypertension (High Blood Pressure) 08/2003
1	Inflammation (Inflammations) 06/2003

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 08/2014
4	Insulin (Novolin)FDA Link 01/2017 - 08/2014
3	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2017 - 02/2014
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 01/2017
2	AmidesIBA 01/2017 - 06/2006
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017 - 06/2006
1	GTP-Binding Proteins (G-Protein)IBA 07/2017
1	Nonesterified Fatty Acids (NEFA)IBA 07/2017
1	Blood Glucose (Blood Sugar)IBA 02/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017
1	BenzamidesIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	Insulin SecretagoguesIBA 01/2017
1	PiperazineIBA 01/2017
1	benzamideIBA 01/2017
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 08/2014
1	Pharmaceutical PreparationsIBA 08/2014
1	AcetanilidesIBA 02/2014
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 06/2006
1	vofopitantIBA 08/2003
1	Chemokine ReceptorsIBA 06/2003

Therapy/Procedure

1	Therapeutics 06/2003